PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy SurgeryGlobeNewsWire • 06/07/23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy SurgeryGlobeNewsWire • 05/01/23
PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy SurgeryGlobeNewsWire • 03/28/23
PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in BunionectomyGlobeNewsWire • 03/16/23
PainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price RequirementGlobeNewsWire • 02/07/23
PainReform to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/01/22
PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20thGlobeNewsWire • 04/12/22
PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30thGlobeNewsWire • 03/21/22
PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022GlobeNewsWire • 03/17/22
PainReform CEO to Participate in the Benzinga All Access Event on December 16thGlobeNewsWire • 12/14/21
PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume TodayInvestorPlace • 11/22/21
PainReform to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021GlobeNewsWire • 10/14/21
PRFX Stock: 7 Things to Know About Pharmaceutical Company PainReform Amid Heavy TradingInvestorPlace • 07/21/21
PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain ReliefGlobeNewsWire • 03/18/21
PainReform to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual ConferenceGlobeNewsWire • 03/11/21